awards grant Deciphering the fitness determinants of clonal mosaicism Investigating novel KRAS inhibitors effects on the tumor-immune responses and integration of KRAS inhibition with immune based therapies. MFCR ASPIRE AWARD Mark Foundation Emerging Leader Award
